NDC 53808-1130
Tivicay 50 mg tablet, film coated
On the label: State of Florida DOH Central Pharmacy. It's repackaged: State of Florida DOH Central Pharmacy rebottles it from ViiV Healthcare Company's NDC 49702-228.
Where the pills inside were made
This label doesn't name the factory that makes the drug. Companies don't have to print it on the label. The maker's name is often on the stock bottle your pharmacy used; you can ask the pharmacist. See the plants ViiV Healthcare Company names for other drugs.
Repackaging site
- State of Florida DOH Central Pharmacy, Location not on file · repackages it
Recalls
- May 13, 2022 · Class III · GlaxoSmithKline LLC
Labeling: incorrect or missing lot and/or expiration date. An incorrect expiration date was printed on the product labeling with an expiration date of January 2027, whereas the correct expiration date is September 2026.
Lots: Lot: 2A9E, Exp 1/2027 - Feb 11, 2014 · Class III · Viiv Healthcare Company
Cross Contamination with Other Products: Product contains Promacta (eltrombopag).
Lots: Lot #: 3ZP2210 Sub-lot A, Expiry: 10/15
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Dolutegravir: every company that makes it
- Form
- tablet, film coated
- Strength
- 50 mg
- Approval
- NDA NDA204790
- On the market since
- Jul 10, 2017
- Package NDCs
53808-1130-1- Official label
- DailyMed (National Library of Medicine), updated Jan 24, 2019
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?